Pharmacogenomics logo Future Medicine logo

Pharmacogenomics provides the community with an essential resource for keeping abreast of the latest developments in new pharmacogenomic initiatives, emerging technologies for accessing genomic information and the development of novel diagnostic products and strategies.

Publisher: Future Medicine

Volume 8, Number 2, February 2007
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial

Heat shock protein - receptor-based pharmacogenomics: the search for new cancer antigens
pp. 117-120(4)
Authors: Stebbing, Justin; Srivastava, Pramod

Nutrigenomics and the prevention of colon cancer
pp. 121-124(4)
Author: Davis, Cindy D

Unraveling hypertension: epigenomics comes of age
pp. 125-128(4)
Author: Fornage, Myriam

Gene-expression profiling in lung cancer: still early days
pp. 129-132(4)
Authors: Yang, Ping; Sun, Zhifu

Bulletin Board

Silent mutations: not so quiet?
pp. 133-135(3)

Conference Scene

The diverse and informative future of microarray applications
pp. 137-140(4)
Author: Putonti, Catherine

Research Report

Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients
pp. 141-150(10)
Authors: van der Straaten, RJHM; Wessels, Judith AM; de Vries-Bouwstra, Jeska K; Goekoop-Ruiterman, Yvonne PM; Allaart, Cornelia F; Bogaartz, Judith; Tiller, Marco; Huizinga, Tom WJ; Guchelaar, Henk-Jan

Review

CYP2A6 polymorphisms: is there a role for pharmacogenomics in preventing coumarin-induced hepatotoxicity in lymphedema patients?
pp. 151-158(8)
Authors: Farinola, Nicholas; Piller, Neil B

Pharmacogenetics of antiparkinsonian drug treatment: a systematic review
pp. 159-176(18)
Authors: Arbouw, Maurits EL; van Vugt, Jeroen PP; Egberts, Toine CG; Guchelaar, Henk-Jan

Perspective

Mapping translational research in personalized therapeutics: from molecular markers to health policy
pp. 177-185(9)
Authors: Ozdemir, Vural; Williams-Jones, Bryn; Cooper, Dan M; Someya, Toshiyuki; Godard, Béatrice

CYP2C8 and antimalaria drug efficacy
pp. 187-198(12)
Authors: Gil, JP; Gil Berglund, E

Priority Paper Evaluation

Comparison of HapMap data on Affymetrix and Illumina platforms: expanding the power of studies and a not so unexpected synergy
pp. 199-201(3)
Author: Dobrin, Seth

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A